Carlsmed, Inc. (CARL)

Carlsmed Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Market Capitalization	267	328	-	-
Enterprise Value	175	231	-	-
Last Close Price	9.99	12.35	-	-
PS Ratio	5.29	6.50	-	-
PB Ratio	2.69	3.32	-	-
P/TBV Ratio	2.70	3.32	-	-
EV/Sales Ratio	3.46	4.56	-	-
Debt / Equity Ratio	0.18	0.18	0.67	-4.14
Net Debt / Equity Ratio	-0.93	-0.93	-0.90	-1.51
Net Debt / EBITDA Ratio	3.05	3.05	0.96	-0.23
Net Debt / FCF Ratio	3.12	3.12	0.90	-0.24
Asset Turnover	0.56	0.56	0.83	-
Inventory Turnover	8.78	8.78	9.07	-
Quick Ratio	8.48	8.48	5.32	1.40
Current Ratio	8.87	8.87	5.60	1.58
Return on Equity (ROE)	-47.62%	-47.62%	-212.36%	-
Return on Assets (ROA)	-21.00%	-21.00%	-45.79%	-
Return on Capital Employed (ROCE)	-26.40%	-26.40%	-56.10%	-282.40%
Earnings Yield	-11.32%	-9.03%	-	-
FCF Yield	-11.09%	-9.02%	-	-
Buyback Yield / Dilution	-249.74%	-249.74%	-4.62%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q